Brigitte Bonan

594 total citations
30 papers, 421 citations indexed

About

Brigitte Bonan is a scholar working on Surgery, Occupational Therapy and Infectious Diseases. According to data from OpenAlex, Brigitte Bonan has authored 30 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 6 papers in Occupational Therapy and 5 papers in Infectious Diseases. Recurrent topics in Brigitte Bonan's work include Safe Handling of Antineoplastic Drugs (6 papers), Pharmaceutical studies and practices (5 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). Brigitte Bonan is often cited by papers focused on Safe Handling of Antineoplastic Drugs (6 papers), Pharmaceutical studies and practices (5 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). Brigitte Bonan collaborates with scholars based in France, Belgium and United States. Brigitte Bonan's co-authors include O. Laccourreye, Nicolas Martelli, Raimundo Gutiérrez-Fonseca, D Brasnu, Dominique Garcia, Daniel Brasnu, Patrice Prognon, Ludovic‐Alexandre Vidal, Evren Şahin and Stéphane Oudard and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Journal of Clinical Epidemiology.

In The Last Decade

Brigitte Bonan

30 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brigitte Bonan France 11 112 102 67 51 48 30 421
Clemente Ponzetti Italy 5 17 0.2× 13 0.1× 29 0.4× 13 0.3× 26 0.5× 9 328
Danya Zhang China 9 75 0.7× 12 0.1× 17 0.3× 31 0.6× 33 0.7× 18 647
Barbara A. McCann United States 5 53 0.5× 232 2.3× 16 0.2× 8 0.2× 51 1.1× 11 566
Arjun Gupta United States 13 241 2.2× 30 0.3× 55 0.8× 2 0.0× 163 3.4× 63 631
Gita N. Mody United States 14 161 1.4× 11 0.1× 11 0.2× 19 0.4× 135 2.8× 60 505
Vinícius Coelho Carrard Brazil 18 135 1.2× 20 0.2× 49 0.7× 1 0.0× 109 2.3× 102 1.1k
Aidan Lyanzhiang Tan Singapore 9 61 0.5× 18 0.2× 11 0.2× 12 0.2× 61 1.3× 20 392
Nobuo Kuramoto Japan 11 40 0.4× 10 0.1× 48 0.7× 1 0.0× 24 0.5× 24 672
Sherry Woodhouse United States 13 278 2.5× 13 0.1× 57 0.9× 2 0.0× 137 2.9× 28 664
Murray Davidson United States 17 290 2.6× 15 0.1× 49 0.7× 4 0.1× 19 0.4× 45 716

Countries citing papers authored by Brigitte Bonan

Since Specialization
Citations

This map shows the geographic impact of Brigitte Bonan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigitte Bonan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigitte Bonan more than expected).

Fields of papers citing papers by Brigitte Bonan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brigitte Bonan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigitte Bonan. The network helps show where Brigitte Bonan may publish in the future.

Co-authorship network of co-authors of Brigitte Bonan

This figure shows the co-authorship network connecting the top 25 collaborators of Brigitte Bonan. A scholar is included among the top collaborators of Brigitte Bonan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brigitte Bonan. Brigitte Bonan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vallée, Alexandre, et al.. (2022). Clinical Benefit of Pembrolizumab in Advanced Urothelial Cancer Patients in Real-Life Setting: An Efficacy and Safety Monocentric Study. Current Oncology. 29(2). 945–955. 6 indexed citations
2.
Vallée, Alexandre, Brigitte Bonan, Philippe Lesprit, et al.. (2021). Oxford–AstraZeneca COVID-19 vaccine: need of a reasoned and effective vaccine campaign. Public Health. 196. 135–137. 10 indexed citations
3.
Bonan, Brigitte, et al.. (2019). Improving safety of preparation and administration of medicines and enteral nutrition in a neonatal care unit: Global risk analysis. Annales Pharmaceutiques Françaises. 78(2). 158–166. 2 indexed citations
5.
Farfour, Éric, Philippe Lesprit, Erwan Fourn, et al.. (2018). Acute hepatitis A breakthrough in MSM in Paris area. AIDS. 32(4). 531–532. 6 indexed citations
7.
Diallo, Stéphanie, Hélène van den Brink, Carole Serrano, et al.. (2017). Existing reporting guidelines for clinical trials are not completely relevant for implantable medical devices: a systematic review. Journal of Clinical Epidemiology. 91. 111–120. 4 indexed citations
8.
Bonan, Brigitte, et al.. (2016). How well Informed are Cancer Patients Prior to a Life Cycle of Injectable Chemotherapy Drug Treatment?. Journal of Cancer Education. 33(1). 74–82. 1 indexed citations
9.
Martelli, Nicolas, et al.. (2012). Use of a risk assessment method to improve the safety of negative pressure wound therapy. International Wound Journal. 11(3). 253–258. 1 indexed citations
10.
Diallo, Stéphanie, et al.. (2012). Evaluating Single-incision Slings in Female Stress Urinary Incontinence: The Usefulness of the CONSORT Statement Criteria. Urology. 80(3). 535–541. 18 indexed citations
12.
Martelli, Nicolas, et al.. (2011). Interest of the preliminary risk analysis method in a central sterile supply department. BMJ Quality & Safety. 20(8). 698–703. 8 indexed citations
13.
Bonan, Brigitte, et al.. (2010). FabAct®: a decision‐making tool for the anticipation of the preparation of anticancer drugs. Journal of Evaluation in Clinical Practice. 16(6). 1129–1135. 6 indexed citations
15.
Bonan, Brigitte, et al.. (2008). Stability of antineoplastic agents in use for home-based intravenous chemotherapy. Pharmacy World & Science. 31(1). 1–13. 16 indexed citations
16.
Bonan, Brigitte, et al.. (2008). The application of hazard analysis and critical control points and risk management in the preparation of anti-cancer drugs. International Journal for Quality in Health Care. 21(1). 44–50. 30 indexed citations
17.
Jacquot, C., et al.. (2005). Prescription Errors with Cytotoxic Drugs and the Inadequacy of Existing Classifications. Pharmacy World & Science. 27(4). 339–343. 20 indexed citations
18.
Banu, Eugéniu, F. Scotté, Asima Banu, et al.. (2004). Corrected area under serum hemoglobin curve (Hb c-AUC) as a predictor of maximal hemoglobin response after erythropoietin (rHuEpo) treatment in chemotherapy induced anemia patients. Journal of Clinical Oncology. 22(14_suppl). 9586–9586. 3 indexed citations
19.
Laccourreye, O., et al.. (1999). Recurrent Gustatory Sweating (Frey Syndrome) After Intracutaneous Injection of Botulinum Toxin Type A. Archives of Otolaryngology - Head and Neck Surgery. 125(3). 283–283. 79 indexed citations
20.
Laccourreye, O., et al.. (1990). Treatment of frey's syndrome with topical 2% diphemanil methylsulfate (prantal®): A double‐blind evaluation of 15 patients. The Laryngoscope. 100(6). 651–653. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026